ESR1 and breast carcinoma: A fundamental study focusing on molecular characterization of different breast cancers has identified major gene signatures that include cells expressing estrogen receptors (ER+), cells lacking ERs (ER-) and expressing the human epidermal growth factor receptor 2 (HER2+), and cells lacking both ERs and HER2 (triple negative breast cancer; TNBC).